QR Page | Allurion

English Français Español Italiano Turkçe Português

English Français Español Italiano Turkçe Português

* Results may vary from one patient to another. The average of 14.2% (+/- 5%) was demonstrated by a clinical study conducted on 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m² (1).
** The removal of the Allurion Balloon may, in very rare cases, require an endoscopic or surgical procedure. In rare cases, instead of being passed through the digestive tract, the deflated balloon may be expelled by vomiting.
*** Eligibility for the placement of an Allurion Balloon will be assessed by a certified doctor after an initial consultation and a thorough review of your medical history. In the case of an extended Allurion Programme, your eligibility will be reassessed before each placement to ensure that you continue to meet the required conditions.

R. Ienca et al. The procedureless Elipse gastric balloon program: Multicenter experience in 1,770 consecutive patients. Obes Surg. 2020;30(9):3354-3362.
A multicentre, prospective, non-randomised, open registry study conducted on overweight or obese patients from January 2016 to June 2019 across 19 international obesity centres participating in the study. A total of 1,770 patients with an average BMI of 34.4 ± 5.3 kg/m² at baseline underwent treatment with the Elipse swallowable gastric balloon, with monthly visits and a total follow-up of 4 months. 63 patients (3.6%) did not complete the programme, and the balloon was removed before 4 months due to intolerance or other adverse effects.
World Health Organization - Key facts about obesity and overweight (who.int).
European survey finds over three-quarters of adults with obesity have attempted to lose weight in the past year, but most have been unsuccessful - EASO
This information is extracted from the device's leaflet - Instructions for use - Allurion Gastric Balloon - CS137-02-ENG-ART. If you have any further questions regarding this document, please consult your doctor.

Chat with Ally

References